Abstract
Background Left ventricular hypertrophy (LVH) is a known marker of increased risk in developing future life-threating CVD, though it is unclear how health risk factors, such as obesity, blood pressure and tobacco use, associate with left ventricular (LV) remodelling and LVH across generations of urban African populations.
Methods Black female adults (n=123; age: 29-68 years) and their children (n=64; age: 4-10; 55% female) were recruited from the Birth to Twenty Plus Cohort in Soweto, South Africa. Tobacco and alcohol use, physical activity, presence of diabetes mellitus, heart disease and medication were self-reported. Height, weight, and blood pressure were measured in triplicate. Echocardiography was used to assess LV mass at end-diastole, perpendicular to the long axis of the LV and indexed to body surface area to determine LVH.
Results Hypertension and obesity prevalence were 35.8% and 59.3% for adults and 45.3% and 6.3% for children. Self-reported tobacco use in adults was 22.8%. LVH prevalence was 35.8% (n=44) in adults (75% eccentric; 25% concentric), and 6.3% (n=4) in children (all eccentric). Prevalence of concentric remodelling was 15.4% (n=19) in adults and observed in one child. In adults, obesity (OR: 2.54 (1.07-6.02; p=0.02) and hypertension (3.39 (1.08-10.62; p=0.04) significantly increased the odds of LVH, specifically eccentric LVH, while concentric LVH was associated with self-reported tobacco use (OR: 4.58 (1.18-17.73; p=0.03; n=11). Although no logistic regression was run within children, of the four children LVH, three had elevated blood pressure and the child with normal blood pressure was overweight.
Conclusions The association between obesity, hypertension, tobacco use and LVH in adults, and the 6% prevalence of LVH in children, calls for stronger public health efforts to control risk factors and monitor children at who are risk.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by a Wellcome Trust Seed Award to Lisa Ware (214082/Z/18/Z). LJW, SAN, and LMS are supported by the DSI-NRF Centre of Excellence in Human Development, University of the Witwatersrand.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee (Medical) of the University of the Witwatersrand approved this work (M190263).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request
Abbreviations
- ASC
- American Society of Echocardiography
- BMI
- body mass index
- BT20+
- Birth to Twenty Plus Cohort
- BP
- blood pressure
- CI
- confidence interval
- CVD
- cardiovascular disease
- GPAQ
- global physical activity questionnaire
- IQR
- interquartile range
- ISH
- International Society of Hypertension
- IVSd
- intraventricular septal diameter
- LVDd
- left ventricular diastolic diameter
- LVPWd
- left ventricular posterior wall thickness in diastole
- LV
- left ventricular
- LVH
- left ventricular hypertrophy
- LVM
- left ventricular mass
- LVMI
- left ventricular mass index
- MVPA
- moderate-vigorous physical activity
- OR
- odds ratio
- RWT
- relative wall thickness
- T2DM
- type II diabetes mellitus
- WHO
- world health organisation
- WHO-AUDIT
- WHO Alcohol Use Disorders
- 1G
- first generation
- 2G
- second generation
- 3G
- third generation